Loading viewer...
investor_presentation
Format: PDF investor_presentation
Defence Therapeutics is a Montreal-based publicly traded biotech company with a patented Accum® platform technology that enhances biotherapeutics potency by 10-100X. The company has FDA clearance for Phase 1 testing of AccuTOX for melanoma and significant licensing opportunities in cancer therapeutics and vaccine development.
investor_presentation
24 Pages
John Bean Technologies Corporation
Vodafone UK Three UK Merger 2023
investor_presentationinvestor_presentation
14 Pages
Vodafone UK and Three UK